Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
SCLN [NASD]
SciClone Pharmaceuticals, Inc.
Index- P/E23.80 EPS (ttm)0.20 Insider Own0.10% Shs Outstand51.96M Perf Week6.49%
Market Cap247.33M Forward P/E10.58 EPS next Y0.45 Insider Trans4.00% Shs Float43.60M Perf Month6.97%
Income11.00M PEG1.69 EPS next Q0.08 Inst Own55.30% Short Float10.27% Perf Quarter-8.81%
Sales127.10M P/S1.95 EPS this Y25.00% Inst Trans-0.32% Short Ratio15.21 Perf Half Y-2.86%
Book/sh2.79 P/B1.71 EPS next Y32.35% ROA6.30% Target Price8.00 Perf Year0.85%
Cash/sh1.65 P/C2.88 EPS next 5Y14.10% ROE7.40% 52W Range4.24 - 6.30 Perf YTD-5.56%
Dividend- P/FCF26.88 EPS past 5Y25.50% ROI5.60% 52W High-24.44% Beta2.36
Dividend %- Quick Ratio3.80 Sales past 5Y18.60% Gross Margin86.10% 52W Low12.26% ATR0.19
Employees570 Current Ratio4.30 Sales Q/Q-1.20% Oper. Margin9.10% RSI (14)58.45 Volatility3.73% 4.24%
OptionableYes Debt/Eq0.01 EPS Q/Q-100.00% Profit Margin8.60% Rel Volume0.52 Prev Close4.67
ShortableYes LT Debt/Eq0.00 EarningsMar 12 BMO Payout0.00% Avg Volume294.39K Price4.76
Recom2.00 SMA205.34% SMA502.44% SMA200-5.23% Volume152,279 Change1.93%
12-Nov-13Reiterated Aegis Capital Buy $9 → $8
16-Jul-13Upgrade Aegis Capital Hold → Buy $9
18-Sep-12Upgrade BWS Financial Hold → Buy $8.25
10-Aug-10Downgrade BWS Financial Buy → Hold $7.25 → $4.50
09-Apr-10Upgrade BWS Financial Hold → Buy $7.25
08-Jul-09Downgrade BWS Financial Buy → Hold $3.25
03-Jun-09Initiated ThinkEquity Buy $5
21-May-09Initiated Rodman & Renshaw Mkt Outperform $5
05-Sep-08Initiated Susquehanna Financial Neutral
23-Apr-14 06:00AM  SciClone Pharmaceuticals Selects rfXcel to Meet China Product Compliance and Anti-Counterfeiting Goal Business Wire
01-Apr-14 06:00AM  SciClone to Present at Needham Healthcare Conference on April 8, 2014 Marketwired
21-Mar-14 01:04PM  SCICLONE PHARMACEUTICALS INC Financials EDGAR Online Financials
18-Mar-14 09:00AM  Vista Partners Initiates Coverage on Soligenix, Inc. (Ticker: SNGX); $5.50 Price Target Marketwired
17-Mar-14 04:52PM  SciClone Reserves $2 Million For FCPA Settlement at The Wall Street Journal
03:33PM  SCICLONE PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online
12-Mar-14 01:15PM  SciClone Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
01:15PM  SciClone Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript
08:30AM   Q4 2013 SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
07:07AM  Q4 2013 SciClone Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
06:12AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
06:00AM  SciClone Reports 2013 Financial Results and 2014 Outlook Marketwired
03-Mar-14 06:00AM  SciClone Pharmaceuticals to Report Financial Results for the Fourth Quarter and Full Year 2013 on March 12th Marketwired
14-Feb-14 02:23PM  People Moves: Milbank, MoneyGram, SciClone, SEC at The Wall Street Journal
10-Feb-14 06:00AM  SciClone Appoints Charles Meng as General Counsel and Vice President of Compliance Marketwired
03-Feb-14 06:00AM  SciClone to Present at BIO CEO & Investor Conference on February 11, 2014 Marketwired
06:00AM  SciClone to Present at BIO CEO & Investor Conference on February 11, 2014 Marketwire
30-Jan-14 06:06PM  Nasdaq stocks posting largest percentage increases AP
01:43PM  Nasdaq stocks posting largest percentage increases AP
29-Jan-14 06:04PM  Nasdaq stocks posting largest percentage increases AP
02:02PM  Nasdaq stocks posting largest percentage increases AP
28-Jan-14 06:03PM  Nasdaq stocks posting largest percentage increases AP +16.70%
01:34PM  Nasdaq stocks posting largest percentage increases AP
27-Jan-14 10:15PM  Harwood Feffer LLP Announces Investigation of SciClone Pharmaceuticals, Inc. PR Newswire -12.65%
10:15PM  Harwood Feffer LLP Announces Investigation of SciClone Pharmaceuticals, Inc.
04:30PM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of SciClone Pharmaceuticals, Inc. PR Newswire
04:30PM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of SciClone Pharmaceuticals, Inc.
10:08AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors SciClone Pharmaceuticals, Inc. PR Newswire
10:08AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors SciClone Pharmaceuticals, Inc.
24-Jan-14 06:30PM  SciClone Announces Transition From Pricewaterhousecoopers LLP to Pricewaterhousecoopers Zhong Tian LLP as Independent Registered Public Accounting Firm Marketwired
06:30PM  SciClone Announces Transition From Pricewaterhousecoopers LLP to Pricewaterhousecoopers Zhong Tian LLP as Independent Registered Public Accounting Firm Marketwire
06:30PM  SciClone Announces Transition From Pricewaterhousecoopers LLP to Pricewaterhousecoopers Zhong Tian LLP as Independent Registered Public Accounting Firm
05:57PM  SciClone says material weakness found in controls at theflyonthewall.com
05:57PM  SciClone says material weakness found in controls
05:02PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements EDGAR Online
05:02PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements
16-Jan-14 02:15PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fin EDGAR Online
02:15PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fin
15-Jan-14 07:00AM  4 Stocks Under $10 Moving Higher at TheStreet
07:00AM  4 Stocks Under $10 Moving Higher
09-Jan-14 11:59AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
11:59AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
06:00AM  SciClone Provides 2013 Financial Update and 2014 Guidance Marketwired
06:00AM  SciClone Provides 2013 Financial Update and 2014 Guidance Marketwire
06:00AM  SciClone Provides 2013 Financial Update and 2014 Guidance
02-Jan-14 03:45PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and EDGAR Online
03:45PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and
02-Dec-13 06:00AM  SciClone to Present at Oppenheimer Healthcare Conference on December 10, 2013 Marketwired
06:00AM  SciClone to Present at Oppenheimer Healthcare Conference on December 10, 2013
19-Nov-13 01:04PM  SCICLONE PHARMACEUTICALS INC Financials EDGAR Online Financials
01:04PM  SCICLONE PHARMACEUTICALS INC Financials
14-Nov-13 04:16PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statement EDGAR Online
04:16PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statement
12-Nov-13 05:13PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online +7.16%
05:13PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
01:20PM  SciClone Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
01:20PM  SciClone Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript
08:30AM  SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
08:30AM  SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today
08:25AM  SciClone Pharmaceuticals, Inc. Discusses Q2 2013 Results (Webcast) at Seeking Alpha
08:25AM  SciClone Pharmaceuticals, Inc. Discusses Q2 2013 Results (Webcast)
07:07AM  Q3 2013 SciClone Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
06:00AM  SciClone Reports Financial Results for the Three and Nine Months Ended September 30, 2013 Marketwired
05-Nov-13 06:00AM  SciClone Pharmaceuticals to Report Financial Results for the Third Quarter, 2013 on November 12th Marketwired
23-Sep-13 10:02AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and EDGAR Online
06:00AM  SciClone Appoints Nancy T. Chang, Ph.D., to Its Board of Directors Marketwired
09-Sep-13 02:31PM  See How SciClone Pharmaceuticals Ranks Among Analysts' Top Picks With Strong Buyback Activity at Forbes
04-Sep-13 06:00AM  SciClone to Present at Four Investor Conferences in September 2013 Marketwired
15-Aug-13 01:04PM  SCICLONE PHARMACEUTICALS INC Financials EDGAR Online Financials
12-Aug-13 05:06PM  SciClone Gets New Subpoena from SEC in FCPA Probe at The Wall Street Journal
05:04PM  SciClone Receives New Subpoena from SEC in FCPA Probe at The Wall Street Journal
02:58AM  Antares Pharma and 4 Stocks in the Trading Spotlight Post Earnings at Wall St. Cheat Sheet
09-Aug-13 06:12AM  SCICLONE PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
07-Aug-13 01:00PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
12:01PM  SciClone Pharmaceuticals Management Discusses Q2 2013 Results - Earnings Call Transcript at Seeking Alpha
11:31AM  SciClone Pharmaceuticals Earnings: Heres Why Investors Dont Like These Results at Wall St. Cheat Sheet
08:30AM  SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
08:19AM  SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
07:34AM  SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
07:07AM  Q2 2013 SciClone Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
06:00AM  SciClone Reports Financial Results for the Three and Six Months Ended June 30, 2013 and Updates 2013 Guidance Marketwired
01-Aug-13 04:00PM  SciClone Pharmaceuticals to Report Financial Results for the Three and Six Months Ended June 30, 2013 on August 7th Marketwired
16-Jul-13 08:42AM  SciClone upgraded to Buy from Hold at Aegis theflyonthewall.com
01:46AM  SciClone Pharma upgraded by Aegis Capital Briefing.com
15-Jul-13 10:14PM  SciClone Hires a CFO at Motley Fool
03:19PM  CFO Moves: BG Group, Allegheny Technologies, SciClone Pharmaceuticals at The Wall Street Journal
01:32PM  SciClone Pharma names Wilson Cheung as CFO AP
11:17AM  SciClone Pharma names Wilson Cheung as CFO AP
06:00AM  InPlay: SciClone Pharma appoints Wilson Cheung as CFO Briefing.com
06:00AM  SciClone Appoints Wilson W. Cheung as Chief Financial Officer Marketwired
14-Jul-13 11:18PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and EDGAR Online
30-Jun-13 03:49AM  China Biotech In Review: Simcere Raises $65 Million By Selling Boda Subsidiary at Seeking Alpha
27-Jun-13 11:08PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or P EDGAR Online +8.00%
25-Jun-13 03:00AM  SciClone and Taiwan Liposome Company Enter Into a Licensing Agreement for ProFlow(R), a Novel Treatment for Peripheral Arterial Disease for the China Market Marketwired
10-Jun-13 02:45PM  See How SciClone Pharmaceuticals Ranks Among Analysts' Top Picks With Strong Buyback Activity at Forbes
31-May-13 09:06AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
28-May-13 06:00AM  SciClone to Present at Jefferies 2013 Global Healthcare Conference Marketwired
06:00AM  SciClone to Present at Jefferies 2013 Global Healthcare Conference Marketwire
19-May-13 09:14AM  China Biotech In Review: SciClone Pharma In-Licenses China Rights To Heart Failure Drug at Seeking Alpha
16-May-13 06:13PM  4 Healthcare Stock Stories For Thursday Investing Wellness at Wall St. Cheat Sheet
SciClone Pharmaceuticals, Inc., a specialty pharmaceutical company, provides therapies for the treatment of oncology, infectious diseases, and cardiovascular disorders primarily in the People's Republic of China. Its lead product is ZADAXIN, which is used for the treatment of hepatitis B and hepatitis C viruses, and certain cancers, as well as for use as a vaccine adjuvant, and as a chemotherapy adjuvant for cancer patients with weakened immune systems. ZADAXIN has approval in approximately 30 countries, which include China, the Pacific Rim, Latin America, Eastern Europe, and the Middle East regions. The company markets and sells ZADAXIN through distribution arrangements, local importers, and distributors. It also markets approximately 10 partnered products in China, including Aggrastat, an interventional cardiology product. The company holds license, promotion, distribution, or marketing agreements with various parties for products, including DC Bead, Abstral, Loramyc, and ondansetron RapidFilm. SciClone Pharmaceuticals, Inc. was founded in 1989 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blobel FriedhelmPresident & CEOFeb 28Buy3.951,0003,95350,036Mar 18 06:44 PM
Blobel FriedhelmPresident & CEONov 30Buy4.151,0004,14849,036Mar 18 06:44 PM
Blobel FriedhelmPresident & CEOAug 31Buy4.241,0004,24248,036Mar 18 06:44 PM
Yin MinVP Compliance & Internal AuditAug 22Option Exercise4.2110,93846,04910,938Aug 26 01:18 PM
Yin MinVP Compliance & Internal AuditAug 22Sale5.5010,93860,1590Aug 26 01:18 PM
Yin MinVP Compliance & Internal AuditAug 20Option Exercise4.2312,50052,87512,500Aug 22 01:36 PM
Yin MinVP Compliance & Internal AuditAug 20Sale5.5012,50068,7500Aug 22 01:36 PM
Xie LanVP Finance, China CFOAug 14Option Exercise5.191,0325,3561,032Aug 16 08:22 PM